OLIVER LAGORE VANVALIN INVESTMENT GROUP – CRISPR Therapeutics AG Transaction History
OLIVER LAGORE VANVALIN INVESTMENT GROUP portfolio value:
$135,000
portfolio value
OLIVER LAGORE VANVALIN INVESTMENT GROUP quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -12.68% | -300 shares | -9K | $65.35 | 2.06K |
| Q2 2022 | share | Increase | +103.00% | 1.2K shares | 70K | $60.77 | 2.36K |
| Q1 2022 | share | Increase | 0.00% | 1.16K shares | 74K | $62.77 | 1.16K |